145 related articles for article (PubMed ID: 22790686)
1. Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria.
Onodera M; Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Omama S; Ogasawara K; Ogawa A; Kuribayashi T; Sakamaki K; Okayama A
Int Heart J; 2012; 53(3):176-81. PubMed ID: 22790686
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk stratification with plasma B-type natriuretic peptide levels in a community-based hypertensive cohort.
Sato K; Segawa T; Tanaka F; Takahashi T; Tanno K; Ohsawa M; Onoda T; Itai K; Sakata K; Omama S; Ogasawara K; Ishibashi Y; Makita S; Okayama A; Nakamura M
Am J Cardiol; 2014 Feb; 113(4):682-6. PubMed ID: 24388621
[TBL] [Abstract][Full Text] [Related]
4. Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study.
Nakamura M; Koeda Y; Tanaka F; Onoda T; Itai K; Ohsawa M; Tanno K; Sakata K; Omama S; Ishibashi Y; Makita S; Ohta M; Ogasawara K; Komatsu T; Okayama A
PLoS One; 2013; 8(12):e81243. PubMed ID: 24312541
[TBL] [Abstract][Full Text] [Related]
5. Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population - Comparisons With C-Reactive Protein and Urinary Albumin.
Nakamura M; Ishibashi Y; Tanaka F; Omama S; Onoda T; Takahashi T; Takahashi S; Tanno K; Ohsawa M; Sakata K; Koshiyama M; Ogasawara K; Okayama A;
Circ J; 2018 Mar; 82(4):1017-1025. PubMed ID: 29386475
[TBL] [Abstract][Full Text] [Related]
6. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
8. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
Li H; Ren Y; Duan Y; Li P; Bian Y
Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population.
Nakamura M; Tanaka F; Onoda T; Takahashi T; Sakuma M; Kawamura K; Tanno K; Ohsawa M; Itai K; Sakata K; Makita S;
Int J Cardiol; 2010 Aug; 143(2):124-9. PubMed ID: 19272660
[TBL] [Abstract][Full Text] [Related]
10. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
11. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
Gerstein HC; Mann JF; Yi Q; Zinman B; Dinneen SF; Hoogwerf B; Hallé JP; Young J; Rashkow A; Joyce C; Nawaz S; Yusuf S;
JAMA; 2001 Jul; 286(4):421-6. PubMed ID: 11466120
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the brain natriuretic peptide (BNP) level and remission of diabetic nephropathy with microalbuminuria: a 3-year follow-up study.
Seki N; Matsumoto T; Fukazawa M
Horm Metab Res; 2015 Feb; 47(2):138-44. PubMed ID: 25409418
[TBL] [Abstract][Full Text] [Related]
15. Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study).
Shaw LJ; Polk DM; Kahute TA; Wong ND; Moon J; Miranda-Peats R; Rozanski A; Friedman JD; Hayes S; Thomson L; Berman DS
Am J Cardiol; 2009 Nov; 104(9):1245-50. PubMed ID: 19840570
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study.
Takahashi T; Nakamura M; Onoda T; Ohsawa M; Tanno K; Itai K; Sakata K; Sakuma M; Tanaka F; Makita S; Yoshida Y; Ogawa A; Kawamura K; Okayama A
Atherosclerosis; 2009 Nov; 207(1):298-303. PubMed ID: 19497572
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of brain natriuretic peptides in hemodialysis patients.
Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic polypeptide in type 2 NIDDM patients with albuminuria.
Nagai T; Imamura M; Inukai T; Mori M
J Med; 2001; 32(3-4):169-80. PubMed ID: 11563815
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M
J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
